J Korean Neuropsychiatr Assoc.  2016 Nov;55(4):407-414. 10.4306/jknpa.2016.55.4.407.

Factors Affecting the Quality of Life of Schizophrenia: Focused on Resilience

Affiliations
  • 1Department of Psychiatry, Seoul Metropolitan Eunpyeong Hospital, Seoul, Korea.
  • 2Department of Psychiatry, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. stakato@seoul.go.kr

Abstract


OBJECTIVES
The purpose of this study was to identify factors, including resilience, that influence the quality of life of schizophrenia patients.
METHODS
Subjects included thirty-eight patients with schizophrenia. Each subject was administered questionnaires regarding their socio-demographic characteristics, resilience, quality of life, and social supports. Depressed mood severity and psychopathology of each patient were determined. The Korean version of the 4th revision of Schizophrenia Quality of Life assessment and the Korean modification of the Scale to Measure Subjective Well-being under Neuroleptic treatment were used to assess quality of life.
RESULTS
Resilience, occupation, income, social supports, psychopathology, and depressed mood were correlated with quality of life. Multiple regression analysis results indicated that depressed mood and income have an effect on quality of life (R²=0.526, p=0.000). Moreover, resilience, social supports, and depressed mood also contributed to quality of life (R²=0.635, p=0.000).
CONCLUSION
The result of this study indicate that psychosocial factors including resilience should be considered when caring for schizophrenia patients.

Keyword

Schizophrenia; Resilience; Quality of life; Depression

MeSH Terms

Depression
Humans
Occupations
Psychology
Psychopathology
Quality of Life*
Schizophrenia*

Reference

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association;2013. p. 102.
2. Carpenter WT Jr, Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull. 1988; 14:645–652.
Article
3. Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs. 2004; 18:Suppl 2. 5–17. discussion 41-43.
4. Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res. 1997; 6:21–26.
5. Awad AG, Voruganti LN. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull. 2000; 26:557–564.
Article
6. Margariti M, Ploumpidis D, Economou M, Christodoulou GN, Papadimitriou GN. Quality of life in schizophrenia spectrum disorders: associations with insight and psychopathology. Psychiatry Res. 2015; 225:695–701.
Article
7. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007; 33:1225–1237.
Article
8. Hamaideh S, Al-Magaireh D, Abu-Farsakh B, Al-Omari H. Quality of life, social support, and severity of psychiatric symptoms in Jordanian patients with schizophrenia. J Psychiatr Ment Health Nurs. 2014; 21:455–465.
Article
9. Lee KU, Bahk WM. A new goal of treatment for schizophrenia: quality of life. Korean J Psychopharmacol. 2006; 17:13–23.
10. Rutter M. Implications of resilience concepts for scientific understanding. Ann N Y Acad Sci. 2006; 1094:1–12.
Article
11. Luthar SS, Cicchetti D, Becker B. The construct of resilience: a critical evaluation and guidelines for future work. Child Dev. 2000; 71:543–562.
Article
12. Masten AS. Resilience in children threatened by extreme adversity: frameworks for research, practice, and translational synergy. Dev Psychopathol. 2011; 23:493–506.
Article
13. Fabrega H Jr. Psychiatric stigma in the classical and medieval period: a review of the literature. Compr Psychiatry. 1990; 31:289–306.
Article
14. Avison WR, Speechley KN. The discharged psychiatric patient: a review of social, social-psychological, and psychiatric correlates of outcome. Am J Psychiatry. 1987; 144:10–18.
15. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013; 39:1296–1306.
Article
16. Cabanyes Truffino J. [Resilience: an approach to the concept]. Rev Psiquiatr Salud Ment. 2010; 3:145–151.
Article
17. Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, et al. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry. 2013; 47:762–771.
Article
18. Tait L, Birchwood M, Trower P. Adapting to the challenge of psychosis: personal resilience and the use of sealing-over (avoidant) coping strategies. Br J Psychiatry. 2004; 185:410–415.
Article
19. Wartelsteiner F, Mizuno Y, Frajo-Apor B, Kemmler G, Pardeller S, Sondermann C, et al. Quality of life in stabilized patients with schizophrenia is mainly associated with resilience and self-esteem. Acta Psychiatr Scand. 2016; 134:360–367.
Article
20. Palmer BW, Martin AS, Depp CA, Glorioso DK, Jeste DV. Wellness within illness: happiness in schizophrenia. Schizophr Res. 2014; 159:151–156.
Article
21. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995; 41:1403–1409.
22. Bozikas V, Parlapani E. Resilience in patients with psychotic disorder. Psychiatriki. 2016; 27:13–16.
23. Kim JH, Yim SJ, Min SK, Kim SE, Son SJ, Wild DJ, et al. The Korean version of 4th Revision of Schizophrenia Quality of Life Scale: validation study and relationship with PANSS. J Korean Neuropsychiatr Assoc. 2006; 45:401–410.
24. Yoon JS, Kook SH, Lee HY, Lee C, Paik IH. The development of a Korean modification of the Scale to Measure Subjective Well-being under Neuroleptic treatment (KmSWN). J Korean Neuropsychiatr Assoc. 2000; 39:987–998.
25. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000; 177:42–46.
Article
26. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995; 10:Suppl 3. 133–138.
Article
27. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003; 18:76–82.
Article
28. Baek HS, Lee KU, Joo EJ, Lee MY, Choi KS. Reliability and validity of the Korean version of the connor-davidson resilience scale. Psychiatry Investig. 2010; 7:109–115.
Article
29. Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988; 26:709–723.
30. Suh SY, Im YS, Lee SH, Park MS, Yoo T. A study for the development of Korean version of the Duke-UNC functional social support questionnaire. J Korean Acad Fam Med. 1997; 18:250–260.
31. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13:261–276.
Article
32. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the Korean version of the positive and negative syndrome scale. J Korean Neuropsychiatr Assoc. 2001; 40:1090–1105.
33. WHO Collaborating Centre for Drug Statistics Methodology. cited 2016 Aug 30. Available from: http://www.whocc.no/atc_ddd_index/.
34. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992; 6:201–208.
Article
35. Kim YK, Won SD, Lee KM, Choi HS, Jang HS, Lee BH, et al. A study on the reliability and validity of the Korean version of the Calgary Depression Scale for Schizophrenia (K-CDSS). J Korean Neuropsychiatr Assoc. 2005; 44:446–455.
36. Alessandrini M, Lançon C, Fond G, Faget-Agius C, Richieri R, Faugere M, et al. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia. Schizophr Res. 2016; 171:27–34.
Article
37. Jang CH, Ahn DH, Lee JI. The quality of life and related psychosocial factors of schizophrenia patients registered in community mental health center. Korean J Biol Psychiatry. 2014; 21:28–35.
38. Tomotake M. Quality of life and its predictors in people with schizophrenia. J Med Invest. 2011; 58:167–174.
Article
39. Mauriño J, Sanjúan J, Haro JM, Díez T, Ballesteros J. Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia. Patient Prefer Adherence. 2011; 5:471–474.
Article
40. Suttajit S, Pilakanta S. Predictors of quality of life among individuals with schizophrenia. Neuropsychiatr Dis Treat. 2015; 11:1371–1379.
Article
41. Siris SG. Depression in schizophrenia: perspective in the era of “Atypical” antipsychotic agents. Am J Psychiatry. 2000; 157:1379–1389.
Article
42. Yoo SY. Developing a prediction model for quality of life in patients with schizophrenia. J Korean Acad Psychiatr Ment Health Nurs. 2014; 23:144–155.
Article
43. Seo DD, Choi KS, Park WR, Lee MR, Kim DY, Yu JC. The effects of mental fitness, social support and psychological distress on suicidal idea of people with schizophrenia using community mental health services. J Korean Neuropsychiatr Assoc. 2014; 53:364–369.
Article
44. Kim KJ, Seol JH, Paik YS, Kim JH. The relationship between quality of life and psychosocial characteristics in patients with schizophrenia. J Korean Neuropsychiatr Assoc. 2004; 43:603–610.
45. Suh HS, Kim CH, Lee HS, Jung YC, Choi YH, Huh SY, et al. Quality of life and psychopathology in patients with schizophrenia: subjective and objective assessment. J Korean Neuropsychiatr Assoc. 2001; 40:1122–1131.
46. Lim M, Sim M, Chae S, Lee WH, Na J, Kim D. Stress coping strategies and quality of life in patients with schizophrenia. J Korean Neuropsychiatr Assoc. 2015; 54:181–187.
Article
47. Shah R, Kulhara P, Grover S, Kumar S, Malhotra R, Tyagi S. Contribution of spirituality to quality of life in patients with residual schizophrenia. Psychiatry Res. 2011; 190:200–205.
Article
48. Mizuno Y, Hofer A, Suzuki T, Frajo-Apor B, Wartelsteiner F, Kemmler G, et al. Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: a cross-sectional study. Schizophr Res. 2016; 175:148–153.
Article
49. Bozikas VP, Parlapani E, Holeva V, Skemperi E, Bargiota SI, Kirla D, et al. Resilience in patients with recent diagnosis of a schizophrenia spectrum disorder. J Nerv Ment Dis. 2016; 204:578–584.
Article
50. Yoshida K, Suzuki T, Imasaka Y, Kubo K, Mizuno Y, Saruta J, et al. Resilience in schizophrenia: a comparative study between a remote island and an urban area in Japan. Schizophr Res. 2016; 171:92–96.
Article
51. Torgalsbøen AK. Sustaining full recovery in schizophrenia after 15 years: does resilience matter? Clin Schizophr Relat Psychoses. 2012; 5:193–200.
Article
52. Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, et al. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014; 13:275–287.
Article
53. Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry. 2016; 173:362–372.
Article
54. Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, et al. The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components. Psychiatr Serv. 2015; 66:680–690.
Article
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr